5.24
price down icon0.57%   -0.03
after-market Handel nachbörslich: 5.32 0.08 +1.53%
loading

Abcellera Biologics Inc Aktie (ABCL) Neueste Nachrichten

pulisher
02:31 AM

AbCellera Biologics shareholders approve director elections and auditor at annual meeting - Investing.com

02:31 AM
pulisher
02:28 AM

Is AbCellera (ABCL) Using Boardroom Oncology Talent to Redefine Its Clinical Ambitions? - simplywall.st

02:28 AM
pulisher
01:04 AM

AbCellera Biologics (ABCL) grants director 111,701 share options - Stock Titan

01:04 AM
pulisher
01:03 AM

AbCellera (ABCL) director Stephen Quake awarded 111,701 share options - Stock Titan

01:03 AM
pulisher
01:02 AM

AbCellera (ABCL) director receives 111,701 share options grant - Stock Titan

01:02 AM
pulisher
12:12 PM

AbCellera (NASDAQ: ABCL) shareholders back directors, auditor and Say-on-Pay - Stock Titan

12:12 PM
pulisher
Jun 11, 2026

Are Medical Stocks Lagging ABCELLERA BIOLG (ABCL) This Year? - MSN

Jun 11, 2026
pulisher
Jun 11, 2026

AbCellera (ABCL) director Sandor Victor reports initial insider status on Form 3 - Stock Titan

Jun 11, 2026
pulisher
Jun 11, 2026

Wall Street Analysts Think ABCELLERA BIOLG (ABCL) Could Surge 85.59%: Read This Before Placing a Bet - MSN

Jun 11, 2026
pulisher
Jun 09, 2026

AbCellera: Q3 Hot Flashes Data Drop Aside, This Stock Is A Difficult Sell (NASDAQ:ABCL) - Seeking Alpha

Jun 09, 2026
pulisher
Jun 09, 2026

Q3 2025 Abcellera Biologics Inc Earnings Call Transcript - GuruFocus

Jun 09, 2026
pulisher
Jun 08, 2026

AbCellera Biologics Hits Day Low of $5.50 Amid Price Pressure - Markets Mojo

Jun 08, 2026
pulisher
Jun 07, 2026

AbCellera Appoints Dr. Victor Sandor to its Board of Directors - BioSpace

Jun 07, 2026
pulisher
Jun 07, 2026

A Look At AbCellera Biologics (ABCL) Valuation After ABCL635 Progress And Strong Q1 Results - Yahoo Finance

Jun 07, 2026
pulisher
Jun 06, 2026

AbCellera’s Shift To Proprietary Drugs Puts ABCL635 And Governance In Focus - Yahoo Finance

Jun 06, 2026
pulisher
Jun 06, 2026

symbol__ Stock Quote Price and Forecast - CNN

Jun 06, 2026
pulisher
Jun 05, 2026

AbCellera appoints Victor Sandor to board of directors - Investing.com UK

Jun 05, 2026
pulisher
Jun 05, 2026

AbCellera appoints Victor Sandor to board of directors By Investing.com - Investing.com South Africa

Jun 05, 2026
pulisher
Jun 05, 2026

AbCellera Biologics bets on hot flash antibody as pipeline pivot gains steam - MSN

Jun 05, 2026
pulisher
Jun 05, 2026

AbCellera Biologics Adds Victor Sandor to Board - TipRanks

Jun 05, 2026
pulisher
Jun 05, 2026

AbCellera appoints Victor Sandor to its Board - TradingView

Jun 05, 2026
pulisher
Jun 05, 2026

AbCellera (NASDAQ: ABCL) appoints oncology leader Dr. Victor Sandor as independent director - Stock Titan

Jun 05, 2026
pulisher
Jun 05, 2026

ABCL News | ABCELLERA BIOLOGICS INC (NASDAQ:ABCL) - ChartMill

Jun 05, 2026
pulisher
Jun 05, 2026

Abcellera Biologics Inc at JPMorgan Healthcare Conference Transcript - GuruFocus

Jun 05, 2026
pulisher
Jun 05, 2026

Q1 2026 Abcellera Biologics Inc Earnings Call Transcript - GuruFocus

Jun 05, 2026
pulisher
Jun 05, 2026

Abcellera Biologics Inc at Bank of America Global Healthcare Conference Transcript - GuruFocus

Jun 05, 2026
pulisher
Jun 04, 2026

AbCellera Biologics Bets on Hot Flash Antibody as Pipeline Pivot Gains Steam - TradingView

Jun 04, 2026
pulisher
Jun 04, 2026

ABCL Stock Jumps As Earnings Beat And Drug Data Fuel Momentum - StocksToTrade

Jun 04, 2026
pulisher
Jun 04, 2026

ABCL: Lead antibody for menopausal hot flashes advances to phase II, targeting a $6B market - TradingView

Jun 04, 2026
pulisher
Jun 03, 2026

AbCellera (NASDAQ: ABCL) CFO exercises 250,000 share options - Stock Titan

Jun 03, 2026
pulisher
Jun 03, 2026

Is AbCellera (ABCL) Turning Upgraded Earnings Forecasts Into a Durable Clinical-Stage Business Model? - simplywall.st

Jun 03, 2026
pulisher
Jun 02, 2026

AbCellera Biologics Hits Day High with 12.47% Surge in Stock Price - Markets Mojo

Jun 02, 2026
pulisher
Jun 02, 2026

AbCellera Biologics Hits Day High with 7.68% Surge in Stock Price - Markets Mojo

Jun 02, 2026
pulisher
Jun 02, 2026

AbCellera Biologics Hits New 52-Week High of $6.79, Up 84% - Markets Mojo

Jun 02, 2026
pulisher
Jun 02, 2026

Abcellera Biologics stock hits 52-week high at 6.52 USD By Investing.com - Investing.com India

Jun 02, 2026
pulisher
Jun 01, 2026

After golden cross, AbCellera Biologics Inc. (ABCL)'s technical outlook is bright - MSN

Jun 01, 2026
pulisher
Jun 01, 2026

Has ABCELLERA BIOLG (ABCL) Outpaced Other Medical Stocks This Year? - MSN

Jun 01, 2026
pulisher
Jun 01, 2026

Abcellera Biologics stock hits 52-week high at 6.52 USD - Investing.com

Jun 01, 2026
pulisher
May 29, 2026

AbCellera Biologics (NASDAQ:ABCL) Is In A Good Position To Deliver On Growth Plans - Moomoo

May 29, 2026
pulisher
May 29, 2026

After Golden Cross, AbCellera Biologics Inc. (ABCL)'s Technical Outlook is Bright - Yahoo Finance

May 29, 2026
pulisher
May 28, 2026

ABCL - Finviz

May 28, 2026
pulisher
May 27, 2026

ABCL Technical Analysis & Stock Price Forecast - Intellectia AI

May 27, 2026
pulisher
May 24, 2026

Does AbCellera (ABCL) Have a Clear Path From ABCL635 Data to a Durable Business Model? - Yahoo Finance

May 24, 2026
pulisher
May 22, 2026

AbCellera Biologics Inc. (ABCL) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

May 22, 2026
pulisher
May 22, 2026

Truist raises AbCellera stock price target on clinical data promise By Investing.com - Investing.com Nigeria

May 22, 2026
pulisher
May 22, 2026

Here’s Why AbCellera (ABCL) is Among the 10 Best Penny Stocks to Buy for Long Term - Insider Monkey

May 22, 2026
$30.04
price up icon 1.04%
$108.53
price up icon 0.65%
$90.54
price up icon 1.12%
$54.87
price down icon 0.76%
ONC ONC
$264.48
price up icon 1.62%
$153.87
price up icon 3.11%
Kapitalisierung:     |  Volumen (24h):